STOCK TITAN

Alvotech files 6-K on commercial team change and Exhibit 99.1

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Alvotech filed a Form 6-K noting organizational changes and furnishing a press release about its commercial team, including the departure of Chief Commercial Officer Anil Okay. The report states that, excluding Exhibit 99.1, this Form 6-K is incorporated by reference into the company’s registration statements on Forms F-3 (File Nos. 333-266136, 333-273262, 333-275111, 333-281684), its F-3ASR (File No. 333-289006), and its S-8 (File No. 333-266881). Exhibit 99.1—the press release dated October 22, 2025—is furnished and not deemed filed, and it is not incorporated by reference under the Securities Act or Exchange Act.

Positive

  • None.

Negative

  • None.

Insights

Leadership change disclosed; administrative filing treatment is standard.

The company reports a change in its commercial leadership with the departure of its Chief Commercial Officer. Such transitions can affect commercial execution, but the notice here is limited to the fact of departure and the furnishing of a press release.

The filing also clarifies technical treatment: the 6-K (excluding the exhibit) is incorporated into multiple registration statements, while the press release is furnished, not filed. This preserves disclosure without attaching Section 18 liability to the exhibit.

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-41421

Alvotech
(Translation of registrant's name into English)

9, Rue de Bitbourg,
L-1273 Luxembourg,
Grand Duchy of Luxembourg

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

 


Incorporation by Reference

This Report on Form 6-K (this “Report”) of Alvotech (the “Company”) excluding Exhibit 99.1 attached hereto, shall be deemed to be incorporated by reference into the Company’s registration statements on Forms F-3 (File Nos. 333-266136, 333-273262, 333-275111 and 333-281684), the Company’s registration statement on Form F-3ASR (File No. 333-289006), and the Company’s registration statement on Form S-8 (File No. 333-266881) and to be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Exhibit 99.1 to this Report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Press Releases

On October 22, 2025, Alvotech issued a Press Release announcing changes to its commercial team, with the departure of Anil Okay, Chief Commercial Officer. A copy of the Press Release is furnished herewith as exhibit 99.1. 


EXHIBIT INDEX 

Exhibit Number Description
   
99.1 Press Release dated October 22, 2025


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Alvotech    
  (Registrant)
   
  
Date: October 22, 2025     /s/ Tanya Zharov    
  Tanya Zharov
  General Counsel
  

FAQ

What did Alvotech (ALVO) disclose in this Form 6-K?

It furnished a press release announcing changes to its commercial team, including the departure of Chief Commercial Officer Anil Okay.

Is the press release (Exhibit 99.1) considered filed with the SEC?

No. Exhibit 99.1 is furnished and not deemed filed, and it is not incorporated by reference under the Securities Act or Exchange Act.

Which registration statements incorporate this 6-K by reference?

Forms F-3 (File Nos. 333-266136, 333-273262, 333-275111, 333-281684), Form F-3ASR (File No. 333-289006), and Form S-8 (File No. 333-266881), excluding Exhibit 99.1.

Who is the departing executive mentioned by Alvotech?

Anil Okay, who served as Chief Commercial Officer.

When was the press release issued?

October 22, 2025.
Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Latest SEC Filings

ALVO Stock Data

1.23B
117.87M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg City